247 results
Page 11 of 13
8-K
EX-99.3
19dmn3q
8 Apr 19
Regulation FD Disclosure
6:05am
8-K
EX-99.1
0lzql
8 Apr 19
Regulation FD Disclosure
6:05am
S-8
EX-99.2
1veei
7 Mar 19
Registration of securities for employees
5:16pm
8-K
EX-99.1
78qxerwy3f ie2emm3kk
7 Mar 19
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Highlights
4:05pm
424B5
i5qzrf29lhmrsyowd
13 Feb 19
Prospectus supplement for primary offering
4:44pm
8-K
EX-1.1
8flfxh3k18h
6 Feb 19
Entry into a Material Definitive Agreement
9:40pm
424B5
mqap1j
6 Feb 19
Prospectus supplement for primary offering
9:37pm
424B5
q1vz2n 6wfsavu0
5 Feb 19
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
94dgg45q0ia40xs
11 Dec 18
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
4:05pm
8-K
EX-99.1
r2vq08req
8 Nov 18
Aeglea BioTherapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
8:00am